Mostrar el registro sencillo del ítem
Regulatory volume decrease and intracellular Ca2+ in murine neuroblastoma cells studied with fluorescent probes
dc.creator | Altamirano, J. | |
dc.creator | Brodwick, M.S. | |
dc.creator | Alvarez-Leefmans, F.J. | |
dc.date.accessioned | 2017-06-29T04:22:15Z | |
dc.date.available | 2017-06-29T04:22:15Z | |
dc.date.issued | 1998 | es_ES |
dc.identifier | 277 | es_ES |
dc.identifier.issn | 0022-1295 | es_ES |
dc.identifier.uri | https://doi.org/10.1085/jgp.112.2.145 | es_ES |
dc.identifier.uri | http://repositorio.inprf.gob.mx/handle/123456789/4971 | |
dc.language.iso | eng | es_ES |
dc.relation | 112 (2) 145-160 p. | es_ES |
dc.relation | versión del editor | es_ES |
dc.rights | acceso cerrado | es_ES |
dc.title | Regulatory volume decrease and intracellular Ca2+ in murine neuroblastoma cells studied with fluorescent probes | es_ES |
dc.type | article | es_ES |
dc.contributor.affiliation | Departamento de Neurobiología, Instituto Mexicano de Psiquiatría, México, D.F. México. | es_ES |
dc.relation.jnabreviado | J GEN PHYSIOL | es_ES |
dc.relation.journal | The Journal of general physiology | es_ES |
dc.identifier.place | Estados Unidos | es_ES |
dc.date.published | 1998 | es_ES |
dc.identifier.organizacion | Instituto Mexicano de Psiquiatría | es_ES |
dc.identifier.eissn | 1540-7748 | es_ES |
dc.identifier.doi | 10.1085/jgp.112.2.145 | es_ES |
dc.description.month | Ago | es_ES |
dc.description.abstractotrodioma | The possible role of Ca2+ as a second messenger mediating regulatory volume decrease (RVD) in osmotically swollen cells was investigated in murine neural cell lines (N1E-115 and NG108-15) by means of novel microspectrofluorimetric techniques that allow simultaneous measurement of changes in cell water volume and [Ca2+]i in single cells loaded with fura-2. [Ca2+]i was measured ratiometrically, whereas the volume change was determined at the intracellular isosbestic wavelength (358 nm). Independent volume measurements were done using calcein, a fluorescent probe insensitive to intracellular ions. When challenged with _40% hyposmotic solutions, the cells expanded osmometrically and then underwent RVD. Concomitant with the volume response, there was a transient increase in [Ca2+]i, whose onset preceded RVD. For hyposmotic solutions (up to __40%), [Ca2+]i increased steeply with the reciprocal of the external osmotic pressure and with the cell volume. Chelation of external and internal Ca2+, with EGTA and 1,2-bis-(o_-aminophenoxy) ethane-N,N,N__,N__-tetraacetic acid (BAPTA), respectively, attenuated but did not prevent RVD. This Ca2+-independent RVD proceeded even when there was a concomitant decrease in [Ca2+]i below resting levels. Similar results were obtained in cells loaded with calcein. For cells not treated with BAPTA, restoration of external Ca2+ during the relaxation of RVD elicited by Ca2+-free hyposmotic solutions produced an increase in [Ca2+]i without affecting the rate or extent of the responses. RVD and the increase in [Ca2+]i were blocked or attenuated upon the second of two _40% hyposmotic challenges applied at an interval of 30–60 min. The inactivation persisted in Ca2+-free solutions. Hence, our simultaneous measurements of intracellular Ca2+ and volume in single neuroblastoma cells directly demonstrate that an increase in intracellular Ca2+ is not necessary for triggering RVD or its inactivation. The attenuation of RVD after Ca2+ chelation could occur through secondary effects or could indicate that Ca2+ is required for optimal RVD responses | es_ES |
dc.subject.kw | Animals | es_ES |
dc.subject.kw | Calcium-Metabolism | es_ES |
dc.subject.kw | Calcium-Pharmacology | es_ES |
dc.subject.kw | Cell Size-Physiology | es_ES |
dc.subject.kw | Chelating Agents-Pharmacology | es_ES |
dc.subject.kw | Egtazic Acid-Analogs & derivatives | es_ES |
dc.subject.kw | Egtazic Acid-Pharmacology | es_ES |
dc.subject.kw | Fluoresceins-Pharmacokinetics | es_ES |
dc.subject.kw | Fluorescent Dyes-Pharmacokinetics | es_ES |
dc.subject.kw | Fura-2-Pharmacokinetics | es_ES |
dc.subject.kw | Glioma | es_ES |
dc.subject.kw | Hybrid Cells-Drug effects | es_ES |
dc.subject.kw | Hybrid Cells-Metabolism | es_ES |
dc.subject.kw | Hypotonic Solutions-Pharmacology | es_ES |
dc.subject.kw | Mice | es_ES |
dc.subject.kw | Neuroblastoma | es_ES |
dc.subject.kw | Neurons-Cytology | es_ES |
dc.subject.kw | Neurons-Drug effects | es_ES |
dc.subject.kw | Neurons-Metabolism | es_ES |
dc.subject.kw | Osmolar Concentration | es_ES |
dc.subject.kw | Rats | es_ES |
dc.subject.kw | Tumor Cells, Cultured-Drug effects | es_ES |
dc.subject.kw | Tumor Cells, | es_ES |
dc.subject.kw | Cultured-Metabolism | es_ES |
dc.subject.kw | Chelating Agents | es_ES |
dc.subject.kw | Fluoresceins | es_ES |
dc.subject.kw | Fluorescent Dyes | es_ES |
dc.subject.kw | Hypotonic Solutions | es_ES |
dc.subject.kw | Egtazic Acid | es_ES |
dc.subject.kw | Calcium | es_ES |
dc.subject.kw | Fura-2 | es_ES |
dc.subject.kw | 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid | es_ES |
dc.subject.kw | Fluorexon | es_ES |
Ficheros en el ítem
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |